Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients

Florian Wimmers, Nienke de Haas, Anja Scholzen, Gerty Schreibelt, Elles Simonetti, Marc J. Eleveld, Huberdina M. L. M. Brouwers, Marjo Beldhuis-Valkis, Irma Joosten, Marien I. de Jonge, Winald R. Gerritsen, I. Jolanda M. de Vries, Dimitri A. Diavatopoulos, Joannes F. M. Jacobs.

Sci. Rep. 7, 43486; doi: 10.1038/srep43486 (2017).

Wimmers, F. et al. Monitoring of dynamic changes in Keyhole Limpet Hemocyanin(KLH)-specific B cells in KLH-vaccinated cancer patients. Sci. Rep. 7, 43486; doi: 10.1038/srep43486 (2017).

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects

Rong Shi PhD, Marek Honczarenko MD, PhD, Sean Zhang MD, Catherine Fleener MS, Johanna Mora PhD, Sun Ku Lee PhD, Reena Wang MD, Xiaoni Liu PhD, Diane E. Shevell PhD, Zheng Yang PhD, Haiqing Wang PhD, Bindu Murthy PharmD.

J Clin Pharmacol. 2017 Feb;57(2):161-172. doi: 10.1002/jcph.791. Epub 2016 Aug 23.

First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28

Poirier N, Blancho G, Hiance M, Mary C, Van Assche T, Lempoels J, Ramael S, Wang W, Thepenier V, Braudeau C, Salabert N, Josien R, Anderson I, Gourley I, Soulillou JP, Coquoz D, Vanhove B

J Immunol. 2016 Dec 15;197(12):4593-4602. Epub 2016 Nov 14.

Relates to Clinical Trial NCT02800811

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.

Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR, Belal A, Ahluwalia MS, Hutson AD

Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352. Epub 2016

Diverse Mechanisms in Immune Activation by Hemocyanins – a Key to Formation of a Potent Immune Response

Vera Gesheva
Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences

IORE Journal of Immunology IJL Vol 1.1 (2016)

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients

Steve Boudewijns, Harm Westdorp, Rutger H.T. Koornstra, Erik H.J.G. Aarntzen, Gerty Schreibelt, Jeroen H.A. Creemers, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries, Winald R. Gerritsen, and Kalijn F. Bol

J Immunother. 2016 Jul; 39(6): 241–248.

Published online 2016 Jun 24. doi:  10.1097/CJI.0000000000000127

FRI0230 Assessment of Safety, Pharmacokinetics and Pharmacodynamics of A Novel anti-CD40 Monoclonal antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients

A. Slade, P. Koo, Y. He, P. Espie, A. Auger-Sarrazin, J. Rush, P. Gergely

Annals of the Rheumatic Diseases, June 2016; Vol 75, Issue Suppl 2.

Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.

Belson, Schmidt, Fernando, Hardes, Scott, Brett, Clark, Oliveira, Davis, McHugh, Stone.

Inflamm Res. 2016 May;65(5):389-404. doi: 10.1007/s-4. Epub 2016 Mar 11.

Exploring the ocean for new drug developments: Marine pharmacology

Harshad Malve

J Pharm Bioallied Sci. 2016 Apr-Jun; 8(2): 83–91

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Roisin E. O’Cearbhaill, Govind Ragupathi, Jianglong Zhu, Qian Wan, Svetlana Mironov, Guangbin Yang, Maria K. Spassova, Alexia Iasonos, Sara Kravetz, Ouathek Ouerfelli, David R. Spriggs, Samuel J. Danishefsky and Paul J. Sabbatini.

Cancers 2016, 8(4), 46; doi:10.3390/cancers8040046

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

Michal Radomski, Herbert J. Zeh, Howard D. Edington, James F. Pingpank, Lisa H. Butterfield,Theresa L. Whiteside, Eva Wieckowski, David L. Bartlett, Pawel Kalinski

Journal for ImmunoTherapy of Cancer20164:24

DOI: 10.1186/s-y

Published: 19 April 2016

Relates to Clinical Trial NCT00558051

Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus

B A Sullivan, W Tsuji, A Kivitz, J Peng, G E Arnold, M J Boedigheimer, K Chiu, C L Green, A Kaliyaperumal, C Wang, J Ferbas, and J B Chung

Lupus Sci Med. 2016; 3(1): e000146.
Published online 2016 Apr 8. doi:  10.1136/lupus-2016-000146

Relates to Clinical Trials: NCT02391259 and NCT00774943

Trophic Relationships between Two Gastropods and Seaweeds in Subtropical Rocky Reefs Based on Stable Isotope Analyses

Alejandra Piñón-Gimate, Mercedes M. Gómez-Valdez, Alejandra Mazariegos-Villarreal and Elisa Serviere-Zaragoza.

Journal of Shellfish Research 35(1):191-197. 2016

Full text 

The Design of a Clostridium diffi cile Carbohydrate-Based Vaccine

Mario A. Monteiro

Chapter 21
Vaccine Design: Methods and Protocols: Volume 1: Vaccines for Human Diseases, Methods in Molecular Biology 

Sunil Thomas (ed.), Vaccine Design: Methods and Protocols: Volume 1: Vaccines for Human Diseases, Methods in Molecular Biology, vol. 1403, DOI 10.1007/978-1-4939-3387-7_21, © Springer Science+Business Media New York 2016 

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

MORENA ANTONILLI, HASSAN RAHIMI, VALERIA VISCONTI, CHIARA NAPOLETANO, ILARY RUSCITO, LARIA GRAZIA ZIZZARI, SALVATORE CAPONNETTO, GIACOMO BARCHIESI, ROBERTA IADAROLA, LUCA PIERELLI, AURELIA RUGHETTI, FILIPPO BELLATI, PIERLUIGI BENEDETTI PANICI, and MARIANNA NUTI2 

Int J Oncol. 2016 Apr; 48(4): 1369–1378.

Published online 2016 Feb 8. doi:  10.3892/ijo.2016.3386

Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma

Daniel Tusé, Nora Ku, Maurizio Bendandi, Carlos Becerra, Robert Collins Jr., Nyla Langford, Susana Inogés Sancho, Ascensión López-Díaz de Cerio, Fernando Pastor, Romy Kandzia, Frank Thieme, Franziska Jarczowski, Dieter Krause, Julian K.-C. Ma, Shan Pandya, Victor Klimyuk, Yuri Gleba, and John E. Butler-Ransohoff.

BioMed Research InternationalVolume 2015 (2015), Article ID 648143 
http://dx.doi.org/10.1155/2015/648143

Development of a 20N Virus Filtration Process for Keyhole Limpet Hemocyanin (KLH) – A High Molecular Weight Protein

L. Milbrandt, C. Brisson, Z. Aguilar, W. Bailey.

Poster presented January 21, 2016

PepTalk
Protein Science Week Conference
San Diego, California
Jan 18-22, 2016 

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.

Semerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E.

Angiogenesis. 2016 Jan;19(1):39-52. doi: 10.1007/s-0. Epub 2015 Sep 29.

Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer

Mayu O Frank, Julia Kaufman, Salina Parveen, Nathalie E Blachère, Dana E Orange, and Robert B Darnell

J Transl Med. 2014; 12: 338.
Published online 2014 Dec 5. doi:  10.1186/s-3

Relates to Clinical Trials:
NCT00289341, NCT00345293, and NCT00893945

Clostridium difficile Surface Polysaccharide-KLH Conjugate Vaccine Induced Th17-Featured Adaptive Immune Responses in Mice

Shuguang Bi

Poster presented December 4, 2015

Society for Glycobiology 2015 Annual Meeting
San Francisco, California
December 1-4, 2015